Home › Cardiovascular Disease › California › Simi Valley
Cardiovascular Disease clinical trials in Simi Valley, CA
4 studies for Cardiovascular Disease are looking for participants at sites in and around Simi Valley (within about 30 miles). Open a study to see who can join and how to contact the study team.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Hope Clinical Research, Canoga Park · 11 mi away
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Interventional Cardiology Medical Group, West Hills · 9 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, West Hills · 9 mi away
- Research Site, Canoga Park · 11 mi away
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Focus Clinical Research, West Hills · 9 mi away
- Interventional Cardiology Medical Group, West Hills · 9 mi away
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- St. Louis, MO20 studies
- Pittsburgh, PA20 studies
- Nashville, TN19 studies
Other studies in Simi Valley
- Type 2 Diabetes8 studies
- Obesity5 studies
- Atherosclerosis4 studies
- Atrial Fibrillation4 studies
- Blood Clots4 studies
- Overweight4 studies
- Heart Failure4 studies
- High Blood Pressure3 studies
- Metabolic Disorders3 studies
- Steatotic Liver Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.